Barcelona, Spain, and Kyiv, Ukraine – March 3, 2026 – Pharmacelera, the deeptech company pushing the limits of computational technologies for drug
Boston and Barcelona — February 23, 2026 — Pharmacelera, a deep-tech company developing and applying high-accuracy Quantum Mechanics and Artificial Intelligence (“deep
Round led by Heran Partners and joined by Clave Capital, Inveready and Bio&Tech Smart Capital Financing will enable Pharmacelera to build ongoing
California, US & Barcelona, Spain — October 13th, 2025 — Together with eMolecules we announce the launch of a new integrated solution combining ExaScreen® with
Cambridge, UK & Barcelona, Spain — August 27th, 2025 — Domainex, a leading integrated drug discovery services company, and Pharmacelera, a pioneer
We are thrilled to announce a collaboration between Pharmacelera and the UMass Chan Medical School aimed to support early-stage drug discovery projects.
Barcelona, Leiden and Uppsala, July 2nd 2024 – Pharmacelera, the leading provider of computational tools for hit discovery, the Leiden Academic Center
Barcelona, Spain, and Kyiv, Ukraine, 07 May 2024. Pharmacelera, the leading provider of computational tools for hit discovery, and Enamine, the developer
